Company Name: Achaogen, Inc.
Achaogen, Inc. is a clinical stage biopharmaceutical company. The company is engaged in the development and commercialization of antibacterials for multidrug resistant (MDR) gram-negative infections.
Ticker Symbol: AKAO (NASDAQ)
Company Website: www.achaogen.com
Social Media: Achaogen LinkedIn
Headquarters: South San Francisco, CA